RT @WHO_Europe: Public policy can support & guide medical innovation to address unmet societal needs for new medicines 💊💉Join us on 3 Feb for our 3rd #OsloMedicinesInitiative webinar on non-price incentives for stimulating affordable pharmaceutical innovation. Register👉https://t.co/hzBYIazkFe https://t.co/yqtXTmy5vs
RT @WHO_Europe: Tune in 📽️on Thursday 20 Jan. for our 2nd webinar under the #OsloMedicinesInitiative, discussing w/experts and practitioners how we can support policy-makers to more effectively finance novel medicines. Register here 👉 https://t.co/PhG1siALtE https://t.co/gDwTPpH514
RT @WHO_Europe: Tune in 📽️on Thursday 20 Jan. for our second webinar under the #OsloMedicinesInitiative, discussing with experts & practitioners how we can support policy-makers to more effectively finance novel medicines. Register here 👉https://t.co/PhG1siALtE https://t.co/F9gVlmIfbo
RT @WHO_Europe: 📽️Tune in tomorrow for our first webinar under the #OsloMedicinesInitiative, discussing with experts and practitioners how we can promote access to novel medicines. Register here 👉 https://t.co/5LNZVkkRYw https://t.co/ImQGSo9e1V
RT @WHO_Europe: Our #OsloMedicinesInitiative is here to promote fair + equitable access to high-priced, novel medicines. Our new series o…
#OsloMedicinesInitiative handler om å jobbe for at flere pasienter skal få tilgang til nye legemidler. Vi må også få en diskusjon rundt nye legemidler og legemiddelpriser. Les mer om Oslo Medicine Initiative og webinarene som starter 13. jan: https://t.co/DNrKygs9Ua @WHO_Europe